Valentis, Inc.
Records under this name other than patents Valentis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,158,348 | Apparatus and Method for Preparative Scale Purification of Nucleic Acids Formerly held Term ended Term ended Sep 12, 2023 · High confidence | Term ended | Term ended Sep 12, 2023 | High confidence |
| US 7,173,116 | Nucleic acid formulations for gene delivery and methods of use Formerly held Term ended Term ended Jun 15, 2022 · From the USPTO record | Term ended | Term ended Jun 15, 2022 | From the USPTO record |
| US 8,236,495 | Process and Equipment for Plasmid Purfication Formerly held Term ended Ended no later than Sep 3, 2021 · Low confidence | Term ended | Ended no later than Sep 3, 2021 | Low confidence |
| US 6,245,520 | Methods for introducing nucleic acids into mammalian cells using imidazolium lipids Formerly held Term ended Term ended Jul 25, 2020 · From the USPTO record | Term ended | Term ended Jul 25, 2020 | From the USPTO record |
| US 7,314,746 | Apparatus and Method for Preparative Scale Purification of Nucleic Acids Formerly held Lapsed on the fee record Ended Jan 1, 2020 · High confidence | Lapsed on the fee record | Ended Jan 1, 2020 | High confidence |
| US 6,534,483 | Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods Formerly held Term ended Term ended Aug 10, 2019 · From the USPTO record | Term ended | Term ended Aug 10, 2019 | From the USPTO record |
| US 6,121,457 | Compositions and methods using novel substituted imidazolium lipids Formerly held Term ended Term ended Oct 30, 2018 · From the USPTO record | Term ended | Term ended Oct 30, 2018 | From the USPTO record |
| US 7,771,945 | Apparatus and Method for Preparative Scale Purification of Nucleic Acids Formerly held Lapsed on the fee record Ended Aug 10, 2018 · High confidence | Lapsed on the fee record | Ended Aug 10, 2018 | High confidence |
| US 6,423,693 | Growth hormone releasing hormone expression system and methods of use, including use in animals Term ended Term ended Jul 24, 2018 · From the USPTO record | Term ended | Term ended Jul 24, 2018 | From the USPTO record |
| US 6,410,228 | Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions Term ended Term ended Jul 14, 2018 · From the USPTO record | Term ended | Term ended Jul 14, 2018 | From the USPTO record |